1606 Corp To Acquire Sanctum Herbal For $7.2M
© Provided by Benzinga 1606 Corp (OTCPK:CBDW) an acquisition-based CBD company, has signed a definitive letter of understanding to purchase 51% of India-based nutraceutical company, Sanctum Herbal Corp. Both parties have agreed to a purchase price of $7.2 million in a...
1606 Corp (OTC | CBDW) Signs $7.2M LOI To Acquire Sanctum Herbal
PHOENIX, March 8, 2023 /PRNewswire/ — 1606 Corp (OTC: CBDW), an acquisition-based CBD company, announces it has signed a definitive letter of understanding to purchase 51% of India-based nutraceutical company, Sanctum Herbal Corp. Both parties have agreed...
2023’s Top CBD and THC Gummies – Where to Buy THC + CBD Edibles in New York
See just how much beloved THC and CBD Gummies can do for your entire system I consider myself lucky to live in a modern age where natural hemp products are not only legal, but also recommended by health professionals around the world. These days, consumers can take...
Pharma Mafia Wants To Conquer Cannabis: Can You Patent A Plant? Jazz Is Trying
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently published collected data on CBD safety, placing the information under its Yellow Card alert system, which lists various adverse reactions to drugs in general. In the report, the agency notes...
US economy sending mixed signals: Here’s what it all means
WASHINGTON (AP) — Maybe it was just too good to be true. For a few weeks in late January and early February, the U.S. economy seemed to have reached a rare sweet spot. Inflation was steadily slowing from painful heights. And growth and hiring remained surprisingly...
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Stock market today: Wall Street slips as markets brace for upcoming report on inflation
NEW YORK — Stocks slipped Wednesday as Wall Street braced for a highly anticipated report on inflation that’s on the way. The S&P 500 fell 31.67, or 0.7%, to 4,467.71 for its sixth drop in the past seven days. The Dow Jones Industrial Average lost...
Pressure BioSciences Inc.: Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders
Since Mid-July Launch into Aggressive Expansion Phase, Company Adds Five New U.S. Distributors and Secures Initial Market-Seeding Orders for Over $300,000 of Revolutionary UltraShear Nano-CBD Product SOUTH EASTON, MA / ACCESSWIRE / August 9, 2023 / Pressure...
Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders
Since Mid-July Launch into Aggressive Expansion Phase, Company Adds Five New U.S. Distributors and Secures Initial Market-Seeding Orders for Over $300,000 of Revolutionary UltraShear Nano-CBD Product SOUTH EASTON, MA / ACCESSWIRE / August 9, 2023 / Pressure...
Why Is 180 Life Sciences (ATNF) Stock Up 38% Today?
InvestorPlace – Stock Market News, Stock Advice & Trading Tips 180 Life Sciences (NASDAQ:ATNF) stock is climbing higher on Wednesday as the cannabis market undergoes a rally. The cannabis sector has been on the rise lately as several companies in it...
Ex-English footballer Dean Windass talks about his love for CBD
It’s no surprise that CBD has taken the UK market by storm, but plenty of shoppers are still puzzled about how to navigate the world of cannabidiol today. From topical creams to soft gel capsules and sugary bears, the list of products seems almost endless. One...
Companhia Brasileira de Distribuição (NYSE:CBD) Q4 2022 Earnings Call Transcript
Companhia Brasileira de Distribuição (NYSE:CBD) Q4 2022 Earnings Call Transcript March 1, 2023 Operator: Welcome to the conference to release results for the Fourth Quarter 2022 for GPA. This video conference is being recorded and will be available at the RI side of...
DEA Concludes MyMD’s Supera-CBD Is Not A Controlled Substance Or Listed Chemical
© Provided by Benzinga MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational cannabinoid Supera-CBD is not currently considered a controlled substance or...
Lexaria’s DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels
© Provided by Benzinga Lexaria Bioscience Corp.’s (NASDAQ: LEXX) (NASDAQ: LEXXW) diabetes animal model study DIAB-A22-1 has been completed and produced at least three positive outcomes including weight loss in obese diabetic-conditioned animals, together with improved...
Lexaria stock jumps 5% as DehydraTECH-CBD shows positive action in diabetes animal model study
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our feedback forum. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your...
Recent Comments